Clearsense Acquires Plug-and-Play AI Analytics Firm

JACKSONVILLE, Fla., Sept. 22, 2021 /PRNewswire/ – Clearsense, an AI-powered data analytics platform company that translates healthcare data into highly consumable insights, today announced the acquisition of Compellon, a privately-held, plug-and-play AI analytics company based in Lake Forest, California. The multi-patented Compellon technology uses AI to re-engineer predictive modeling, removing the technical burden from users. The technology is a hand in glove complement to the end-to-end Clearsense platform which cleans, organizes, and enriches data to transform it into ready-to-use, insights that users trust.
Clearsense Co-founder and Chief Innovation Officer Charles Boicey stated, “Compellon’s game changing technology directly supports our mission to rapidly make data analytics nearly as easy as a Google query for clinicians and everyday users.” Boicey added, “With this solution, clinicians and other users can bypass the arduous, time-consuming manual process of testing hypothesis, and see results in hours instead of weeks or more.” The Compellon predictive modeling solution is a cornerstone of the Clearsense advanced analytics and research platform.
Make faster decisions with community advice
- AI Gets Better At Writing Patient Histories When Physicians Engineer The Prompts
- New Study Evaluates Virtual Reality to Reduce Scanxiety in Brain Tumor Patients
- Revolutionizing Healthcare: Harnessing the Power of IoT Solutions for Improved Patient Outcomes
- Carrum Health Raises $45 Million Series B to Expand Cancer Care Offerings and Launch New Service Lines
- Ethical Guardrails Are Essential To Making Generative AI Work For Healthcare
Deploy this technology today
-
nQ Cortex
Matched with Medical Subject Headings (MeSH): Biomedical Technology, Healthcare IT News: Artificial Intelligence
- NLabviva Platform
- Labviva Platform
- AI Dermatologist Platform
- Armis Platform for Healthcare